SI0699680T1 - Oxazoloquinolinone derivatives, their preparation and their use in therapy - Google Patents

Oxazoloquinolinone derivatives, their preparation and their use in therapy

Info

Publication number
SI0699680T1
SI0699680T1 SI9530413T SI9530413T SI0699680T1 SI 0699680 T1 SI0699680 T1 SI 0699680T1 SI 9530413 T SI9530413 T SI 9530413T SI 9530413 T SI9530413 T SI 9530413T SI 0699680 T1 SI0699680 T1 SI 0699680T1
Authority
SI
Slovenia
Prior art keywords
therapy
preparation
oxazoloquinolinone
derivatives
oxazoloquinolinone derivatives
Prior art date
Application number
SI9530413T
Other languages
English (en)
Slovenian (sl)
Inventor
Samir Jegham
Jean Jacques Koenig
Frederic Puech
Philippe Burnier
Lydia Zard
Original Assignee
Sanofi - Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi - Synthelabo filed Critical Sanofi - Synthelabo
Publication of SI0699680T1 publication Critical patent/SI0699680T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Quinoline Compounds (AREA)
SI9530413T 1994-09-05 1995-09-01 Oxazoloquinolinone derivatives, their preparation and their use in therapy SI0699680T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9410600A FR2724171B1 (fr) 1994-09-05 1994-09-05 Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique
EP95401989A EP0699680B1 (de) 1994-09-05 1995-09-01 Oxazolochinolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
SI0699680T1 true SI0699680T1 (en) 2000-10-31

Family

ID=9466686

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530413T SI0699680T1 (en) 1994-09-05 1995-09-01 Oxazoloquinolinone derivatives, their preparation and their use in therapy

Country Status (28)

Country Link
US (1) US5641785A (de)
EP (1) EP0699680B1 (de)
JP (1) JP4225585B2 (de)
KR (1) KR100392523B1 (de)
CN (1) CN1055472C (de)
AT (1) ATE190311T1 (de)
AU (1) AU687591B2 (de)
CA (1) CA2157427C (de)
CZ (1) CZ286128B6 (de)
DE (1) DE69515402T2 (de)
DK (1) DK0699680T3 (de)
ES (1) ES2145886T3 (de)
FI (1) FI110945B (de)
FR (1) FR2724171B1 (de)
GR (1) GR3033554T3 (de)
HK (1) HK1013652A1 (de)
HU (1) HU218587B (de)
IL (1) IL115276A (de)
NO (1) NO306617B1 (de)
NZ (1) NZ272920A (de)
PL (1) PL184412B1 (de)
PT (1) PT699680E (de)
RU (1) RU2141482C1 (de)
SI (1) SI0699680T1 (de)
SK (1) SK281867B6 (de)
TW (1) TW356467B (de)
UA (1) UA41916C2 (de)
ZA (1) ZA957414B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (de) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Verwendung von Monoamin Oxydase Inhibitoren zu Herstellung eines Medikaments zur Behandlung der Fettleibigkeit
US7553967B2 (en) * 2004-03-12 2009-06-30 Wyeth 1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections
AU2008226649B2 (en) * 2007-03-09 2013-08-01 Sanofi Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN105949120B (zh) * 2016-05-27 2018-07-24 广东工业大学 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
ES2013391A6 (es) * 1989-02-08 1990-05-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法

Also Published As

Publication number Publication date
FI954141A (fi) 1996-03-06
NO953458L (no) 1996-03-06
NO953458D0 (no) 1995-09-04
DE69515402D1 (de) 2000-04-13
RU2141482C1 (ru) 1999-11-20
PL184412B1 (pl) 2002-10-31
UA41916C2 (uk) 2001-10-15
US5641785A (en) 1997-06-24
SK108995A3 (en) 1996-06-05
IL115276A (en) 1998-12-06
HU218587B (hu) 2000-10-28
EP0699680A1 (de) 1996-03-06
DE69515402T2 (de) 2000-10-19
ATE190311T1 (de) 2000-03-15
SK281867B6 (sk) 2001-08-06
EP0699680B1 (de) 2000-03-08
FR2724171A1 (fr) 1996-03-08
CZ286128B6 (cs) 2000-01-12
KR960010648A (ko) 1996-04-20
ES2145886T3 (es) 2000-07-16
FI954141A0 (fi) 1995-09-04
FR2724171B1 (fr) 1997-01-03
PL310273A1 (en) 1996-03-18
IL115276A0 (en) 1996-01-19
DK0699680T3 (da) 2000-08-21
AU3041595A (en) 1996-03-21
GR3033554T3 (en) 2000-09-29
CA2157427A1 (en) 1996-03-06
HU9502578D0 (en) 1995-11-28
AU687591B2 (en) 1998-02-26
HK1013652A1 (en) 1999-09-03
FI110945B (fi) 2003-04-30
TW356467B (en) 1999-04-21
NZ272920A (en) 1998-03-25
JP4225585B2 (ja) 2009-02-18
CN1128763A (zh) 1996-08-14
CN1055472C (zh) 2000-08-16
CA2157427C (en) 2010-06-01
CZ226295A3 (en) 1996-03-13
KR100392523B1 (ko) 2003-11-12
NO306617B1 (no) 1999-11-29
JPH0899881A (ja) 1996-04-16
ZA957414B (en) 1996-04-15
HUT73435A (en) 1996-07-29
PT699680E (pt) 2000-08-31

Similar Documents

Publication Publication Date Title
AU8343391A (en) Hair treatment composition
FI945703A0 (fi) 3,4,4-trisybstituoitujen piperidinyyli-N-alkyylikarboksylaattien ja välituotteiden valmistus
TW280773B (de)
MX9603560A (es) Composiciones de prostaglandinas estables en almacenamiento.
DE3572653D1 (en) Diaryl acetylenes, their preparation and use
PT889886E (pt) Novas fenantridinas substituidas na posicao 6
GR3033554T3 (en) Oxazoloquinolinone derivatives, their preparation and their use in therapy
DE69501033D1 (de) Sonnenfilter, diese enthaltende kosmetische Lichtschutzzusammensetzungen sowie deren Verwendung
FI913391A0 (fi) Foerfarande foer detektering av smaocellcarcinom och anvaendning av acylpeptidhydrolas och denna kodande sekvenser.
GR3033123T3 (en) Tricyclic derivatives, their preparation, their use in the preparation of optically active or racemic colchicine, thiocolchicine and analogues or derivatives, and intermediates
FR2716198B1 (fr) Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
FI951323A (fi) Polyjodatut yhdisteet, menetelmä niiden valmistamiseksi ja diagnostiset koostumukset
EP0532629A4 (de)
EP0512744A3 (en) Hair treatment composition containing a perfluoropolyether compound and a pearlescing agent
FI912269A (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
ZA913920B (en) Therapeutic compound
DE3865521D1 (de) 4-methyl-4-phenyl-1-pentanale, deren herstellung und verwendung als riechstoffe.
FR2648813B1 (fr) Nouveaux derives terpeniques, leur preparation et leur emploi